by Paul Krzyzanowski | Jan 24, 2012
Repurposing known drugs for new applications is a strategy with fascinating potential, with two of the most notable examples being Thalidomide and Viagra. Thalidomide was commonly used in the late 1950s as a sedative in pregnant women, later being associated with...
by David Kent | Jan 6, 2012
Yesterday, a landmark paper emerged from Cell which reported two major findings to the scientific community: Primate embryonic stem cells cannot generate chimeras, and Aggregation and injection of multiple early-stage four-cell primate embryos (not embryonic stem...
by Lisa Willemse | Dec 21, 2011
In a traditional view of medical research, advances tend to be measured against the overarching goal of cure. Noble as this might be, research is rarely such a black and white affair — if we have learned anything, it’s that there are innumerable shades of grey....
by Stem Cell Network | Dec 14, 2011
When we report on breakthroughs in stem cell research, we typically link to well-funded studies published in peer-reviewed journals by world-renowned scientists. This time, it’s a little different. Angela Zhang, a high school senior from Cupertino, California, was...
by Angela C. H. McDonald | Dec 13, 2011
Last spring, I wrote about the remarkable generation of self-organizing retinal tissue created from mouse embryonic stem cells. The study successfully created all major retinal components including photoreceptors, albeit at a low abundance. However, while...
by David Kent | Dec 6, 2011
From the depths of the poetic frivolity of Raphael de la Ghetto come some words that might help guide us through one of the most interesting concepts being pursued by stem cell biologists these days. Specifically, research has emerged which links stem cell behaviour...
Comments